×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Sun, MedImmune end dispute on Ethyol drug

Sun, MedImmune end dispute on Ethyol drug
Comment E-mail Print Share
First Published: Tue, Aug 04 2009. 12 04 AM IST
Updated: Tue, Aug 04 2009. 12 04 AM IST
New Delhi:Sun Pharmaceutical Industries Ltd, India biggest drug maker by market value, said the company and its subsidiaries settled a lawsuit with MedImmune Inc. on a generic version of the cancer drug Ethyol.
MedImmune granted Sun a licence to certain patents allowing the Indian company to continue to sell the generic version in the US, the Mumbai-based company said in a statement to the Bombay Stock Exchange on Monday.
Comment E-mail Print Share
First Published: Tue, Aug 04 2009. 12 04 AM IST
More Topics: Sun | MedImmune | Ethyol | Drugs | Corporate News |